ILLIYOON MD Red-itchy Cure Balm 60mL Special Set (Special Gift: Red-itchy Oil 20mL)

4.6/5.0 (1 ratings)

Best Deal
Olive Young
$16.00
Free shipping $60+

ILLIYOON MD Red-itch Cure Balm is a focused care for dry and repeatedly irritated areas by soothing the skin, strengthening the barrier, and creating a moisturizing protective film. Olive Young exclusive product. For those who have been waiting for the re-launch of the discontinued product, everything has been upgraded to the ILLIYOON MD Red-itch Cure Balm, maintaining all of its advantages. For weak lips and cheeks, frequent external stimuli, child’s weak skin, repeated external stimuli, a weak face and neck, dry and prone external stimuli, and dry and prone areas of concern, we recommended this product for external stimuli. With ILLIYOON's amazing form-fitting technology, you can easily form-fit to any part of your body without any burden for wide-area application, oily residue or stickiness. ILLIYOON, a representative body care brand, topped the body care market in the first half of 2021 according to the KANTAR Panel so you can trust the outstanding product. ILLIYOON MD Red-itch Cure Balm is recommended for those with troubled skin problems. After conducting continuous testing for sensitive skin and it was proven to be suitable for all ages, from infants to adults, allowing for low-stimulus skincare. Completed the low skin irritation test with 0.00% index, and tested non-allergenic, so it is safe for use. A low-irritant cure balm for the whole family. This is a functional cream that has been approved by the Ministry of Food and Drug Safety, and it has passed the skin test for children and the extremely sensitive adult skin, so you can be assured of its safety. A cure balm that is used when your skin feels itchy.

Community Q&A

No questions available. Ask the first one!

Reviews (1)

4.6
1 Review
Olive Young
4.6/5.0 32 Reviews

You May Also Like

ILLIYOON MD Red-itchy Care Cream 330mL
ILLIYOON
1
$35 $28 -20%
ILLIYOON Ultra Repair Cream 200ml
ILLIYOON
1
$29 $18.4 -37%